Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Præsentation
Citationsformater

Ann-Brit Eg Hansen
Obel, Niels
H Nielsen
C Pedersen
Gerstoft, Jan

The aim of the study was to compare changes in bone mineral density (BMD) over 144 weeks in HIV-infected patients initiating nucleoside reverse transcriptase inhibitor (NRTI)-sparing or protease inhibitor-sparing highly active antiretroviral therapy (HAART).

Originalsprog	Engelsk
Tidsskrift	HIV Medicine
Vol/bind	12
Udgave nummer	3
Sider (fra-til)	157-65
Antal sider	9
ISSN	1464-2662
DOI	https://doi.org/10.1111/j.1468-1293.2010.00864.x
Status	Udgivet - 1 mar. 2011

ID: 40155059